Q1 2024 Holdings
Filed 2024-05-15 | 8 holdings | $80.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | COM | 92539P101 | $26.7M | 2,008,809 | 33.2% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $22.8M | 11,055,554 | 28.4% |
| Gossamer BIO, Inc.(GOSS) | COM | 38341P102 | $9.5M | 8,055,916 | 11.8% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $7.8M | 381,249 | 9.7% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $5.5M | 320,482 | 6.8% |
| Cero Therapeutics Holdings, Inc. | CLASS A COM | 71902K105 | $4.4M | 1,444,296 | 5.5% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $2.0M | 3,798,926 | 2.4% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $1.6M | 1,004,817 | 2.1% |